Immunology and Microbiology
Amplified Fragment Length Polymorphism
100%
Antifungal Susceptibility
89%
Cryptococcus gattii
76%
Cryptococcus neoformans
67%
Minimum Inhibitory Concentration
65%
Candida
56%
Infectious Agent
46%
Aspergillus fumigatus
40%
Candida Auris
39%
Real-Time Polymerase Chain Reaction
39%
Sporothrix
35%
Matrix-Assisted Laser Desorption-Ionization
35%
Cladistics
34%
Prevalence
32%
Aspergillus
31%
Time-of-Flight Mass Spectrometry
30%
Candida parapsilosis
29%
Filobasidiella
27%
Genetic Variability
26%
Wild Type
24%
Molecular Epidemiology
24%
Trichosporon
24%
Fusarium
23%
Lineage
21%
Antifungal Resistance
21%
Paracoccidioides
20%
Multilocus Sequence Typing
20%
Type Strain
20%
Polymerase Chain Reaction
17%
Candida albicans
17%
Serotype
16%
Mortality Rate
13%
Geographic Distribution
13%
Genome Sequencing
13%
Terbinafine
13%
Candida glabrata
12%
Human immunodeficiency virus
12%
Species Identification
11%
Mould
11%
Molecular Typing
11%
Fusarium oxysporum
10%
EcoRI
10%
Broth Dilution
10%
Next Generation Sequencing
10%
DNA Sequence
9%
Immunocompromised Patient
9%
Keratitis
9%
Multiplex Polymerase Chain Reaction
9%
Calmodulin
9%
Allele
9%
Keyphrases
Antifungal Susceptibility
68%
Genotype
56%
Cryptococcus Neoformans
54%
Candida Auris
47%
Gattii
44%
Species Complex
40%
Itraconazole
39%
Fumigatus
39%
Aurès
38%
Fluconazole
38%
Voriconazole
38%
Amplified Fragment Length Polymorphism
35%
Neoformans
35%
Amphotericin B
32%
Cryptococcus Gattii
30%
Fungi
30%
Azole Resistance
29%
Aspergillus Fumigatus
28%
Posaconazole
25%
Immunocompromised Patients
23%
Candida Parapsilosis
23%
Cryptococcus Gattii Species Complex
22%
Molecular Characterization
22%
Keratitis
22%
Candida
22%
Fusarium
21%
Isavuconazole
21%
Yeast Species
19%
Paracoccidioidomycosis
19%
Azoles
19%
Sporothrix
19%
Microsatellite Typing
18%
Clinically Significant
18%
India
18%
Matrix-assisted Laser Desorption Ionization-time of Flight Mass Spectrometry (MALDI-TOF MS)
18%
Quantitative PCR
17%
Brazil
17%
Candidemia
17%
Phenotypic Diversity
17%
Antifungal Resistance
17%
Antifungal Therapy
17%
Resistance Mechanisms
16%
Parapsilosis
16%
Mating Type
16%
Azole-resistant Aspergillus Fumigatus
16%
International Guidelines
16%
Genetic Diversity
15%
Multidrug-resistant
15%
Epidemiology
14%
Etiological Agents
14%